自身免疫性肝病的免疫发病机制:主题与概念
本文综述了原发性胆汁性胆管炎、原发性硬化性胆管炎和自身免疫性肝炎的病因与发病机制,强调遗传风险、环境因素和肠道菌群失调导致免疫细胞功能障碍及胆汁酸信号异常,并指出当前治疗非特异性且不能治愈,需基于机制开发新疗法。
要点
- 自身免疫性肝病治疗非特异性且不能治愈,肝移植需求高。
- 遗传风险、环境因素和肠道菌群失调共同参与发病。
- 免疫细胞功能障碍和胆汁酸信号异常是关键机制。
核心结论
- 自身免疫性肝病需基于发病机制开发有效疗法。
研究设计与样本
- 综述,总结自身免疫性肝病的病因和发病机制概念。
主要发现
- 遗传风险、环境因素和肠道菌群失调导致免疫细胞功能障碍和胆汁酸信号异常。
临床怎么用
- 临床实践应关注发病机制以指导新疗法开发。
局限性
- 当前治疗非特异性、效果不一且不能治愈。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autoimmune liver diseases include primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis, a family of chronic immune-mediated disorders that target hepatocytes and cholangiocytes. Treatments remain nonspecific, variably effective, and noncurative, and the need for liver transplantation is disproportionate to their rarity. Development of effective therapies requires better knowledge of pathogenic mechanisms, including the roles of genetic risk, and how the environment and gut dysbiosis cause immune cell dysfunction and aberrant bile acid signaling. This review summarizes key etiologic and pathogenic concepts and themes relevant for clinical practice and how such learning can guide the development of new therapies for people living with autoimmune liver diseases.
引用
- Trivedi PJ, Hirschfield GM, Adams DH, et al. Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts. Gastroenterology. 2024. PMID: 38342195. doi:10.1053/j.gastro.2024.01.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。